連結子会社の決算期変更に伴う増減、感染症拡大に伴う損失、貸倒引当金繰入額他1件
- 【期間】
| 年度 | 連結子会社の決算期変更に伴う増減 | 感染症拡大に伴う損失 | 貸倒引当金繰入額 | 資本剰余金 |
|---|
| 2007/03 | - | | - | | - | | 4.52億 | |
| 2008/03 | - | | - | | - | | 4.53億 | +0.2% |
| 2009/03 | - | | - | | - | | 4.47億 | -1.3% |
| 2010/03 | - | | - | | - | | 148億 | 大幅増 |
| 2011/03 | - | | - | | - | | 75.2億 | -49.1% |
| 2012/03 | - | | - | | - | | 75.5億 | +0.4% |
| 2013/03 | -1百万 | | - | | 336百万 | | 74.1億 | -1.8% |
| 2014/03 | - | | - | | 230百万 | -31.5% | 74.1億 | ±0% |
| 2015/03 | - | | - | | 152百万 | -33.9% | 74.1億 | ±0% |
| 2016/03 | - | | - | | 74百万 | -51.3% | 72.5億 | -2.3% |
| 2017/03 | - | | - | | 31百万 | -58.1% | 72.5億 | -0% |
| 2018/03 | - | | - | | 57百万 | +83.9% | 72.5億 | ±0% |
| 2019/03 | - | | - | | 71百万 | +24.6% | 72.5億 | ±0% |
| 2020/03 | - | | 3.05億 | | 210百万 | +195.8% | 72.5億 | ±0% |
| 2021/03 | - | | 36.1億 | 大幅増 | 90百万 | -57.1% | 72.5億 | ±0% |
| 2022/03 | - | | 9.74億 | -73% | 50百万 | -44.4% | 72.5億 | ±0% |
| 2023/03 | - | | 0.9億 | -90.8% | -3百万 | 赤転 | 72.5億 | ±0% |
| 2024/03 | - | | - | | - | | 72.5億 | ±0% |
